secwatch.observer — SEC 8-K summary
======================================

Issuer:     TC BioPharm (Holdings) plc (—)
CIK:        0001872812
Form:       8-K
Filed at:   2024-01-04T23:59:59+00:00
Accession:  0001493152-24-000587
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TC BioPharm regains Nasdaq minimum bid price compliance, avoids delisting
-------------------------------------------------------------------------

- Received Nasdaq confirmation on Jan 2, 2024, that bid price exceeded $1.00 for 10 consecutive days through Dec 29, 2023.
- Had been out of compliance since June 22, 2023, and initial 180-day cure period expired Dec 19, 2023.
- Company not eligible for second 180-day extension, but regained compliance before delisting became effective.
- Press release issued Jan 4, 2024; matter is closed with Nasdaq.
- Resolution removes overhang of potential transfer to OTC or other exchange.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1872812/000149315224000587/0001493152-24-000587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1872812/000149315224000587/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-000587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer